// App-Quantinova.ai

: Phase II trial of SM 88 in non-metastatic biochemical recurrent prostate cancer.

Researchers

Presenter

  • Mack Roach

Principal Investigators

  • Zachary Gostout

  • Patricia Zawisny

  • Avi S. Retter

  • Gerald H. Sokol

  • Steve Hoffman

  • Giuseppe Del Priore

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • Tyme Technologies, Inc., New York, NY

  • Eastchester Center for Cancer Care, Bronx, NY

  • Florida Cancer Institute New Hope, Hudson, FL

  • Morehouse School of Medicine, Atlanta, GA

Locations

  • United States

Companies

  • Tyme Technologies In

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • NCT02796898

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved